SIC 2836 | NAICS 325414
The following guide to industry information, research, and analysis provides sources for industry trends and statistics, market research and analysis, financial ratios and salary surveys, and more.
Select from the following sections or scroll below to view available resources:
For guides to other industries, see our index of over 400 industries.
Comprehensive market research reports provide in-depth industry analysis and five-year forecasts, with special focus on the underlying structure and external forces and relationships that affect industries and their performance. Report contents include:
Daily online news source and weekly report on market data and business trends provide in-depth coverage of the biopharmaceutical industry, with topics covered by these news sources including new product development, clinical trials, FDA approvals, regulatory updates, market performance, corporate financings, strategic alliances, mergers and acquisitions, and corporate restructurings.
First Research profiles cover key aspects of an industry's size, scope, and operations and include a five-year growth forecast. Profile contents include:
Biennial report examines the economic value of bioscience innovation on an national and state basis, with topics covered on a state-by-state basis including establishment, employment, and wage trends, research and development expenditures, NIH funding levels, venture capital investments, and patent awards by bioscience-related class group. Full study and individual state profiles are available online.
Annual E&Y publication analyzes key trends and their implications for the biotechnology sector in the U.S. and Europe, with content sections including the year in review, perspectives on selected topics from industry experts, key financial performance measures, capital financing activities, mergers and acquisitions, and strategic alliances. Current and prior reports can be downloaded and viewed online.
Comprehensive report provides in-depth analysis of the biotechnology sector, with topics covered in the report including major trends and developments, public offerings and other financing and capital sources, mergers and acquisitions, underwriter and stock performance, restructuring transactions, and pending litigation. Detailed table of contents and excerpts from the report can be viewed online.
Standard & Poor's survey provides in-depth coverage of the biotech industry, with topics covered in the report including industry performance and trends, operational overview, and key industry ratios and statistics, and with companies covered in the comparative company analysis section including Abbvie Inc., Amgen, Inc., Biogen, Inc., Gilead Sciences, Inc., and Regeneron Pharmaceuticals, Inc.
Comprehensive market research report provides in-depth analysis of the biopharmaceutical market in the U.S. and other countries, with data provided including historical and forecast sales by product segment (e.g., recombinant proteins, monoclonal antibodies, insulin, and vaccines) and companies profiled including AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Pfizer, Inc., and Novartis AG.
Five-year financial statement analysis includes income statements, balance sheets, and key financial ratios, with data available by sales size range on a national, state, and metro area level.
Financial information section of this profile provides income statements, balance sheets, and financial ratios by company size range based on annual net sales for companies that use living cells and their components to manufacture drugs, therapies, vaccines, and other products, with major companies in this sector including Amgen, Inc., Biogen, Inc., Genetech, Inc., Novo Nordisk A/S, and Monsanto Co.
Annual executive compensation study provides an in-depth look at salaries, bonuses, other short-term and long-term incentives, and total direct compensation for top-level executives (e.g., chief executive officer, chief financial officer, chief operating officer, research and development officer, business and corporate development officer, and legal officer) of publicly-traded U.S. biopharmaceutical companies.
Annual salary survey provides compensation data for personnel employed by companies engaged in medical, agricultural, and industrial biotechnology activities, with compensation information provided for 12 executive and 153 non-executive salaried job positions including annual base salary, incentive and variable pay such as bonuses, commissions, and rewards, and total direct annual compensation.
Excel spreadsheet provides deal-level data for publicly-announced mergers and acquisitions in this sector over a two-year period, with information provided for these transactions including price paid, deal terms, acquisition target financial performance, and price/revenue and price/income multiples. Single-page excerpt from the spreadsheet that includes sample transaction data is available online.